Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,116 | 165,810 | 100,376 | 33,880 | 37,940 |
| Marketable Securities | 484,848 | 539,929 | 614,194 | 773,844 | 813,918 |
| TOTAL | $608,209 | $715,598 | $738,703 | $827,017 | $866,023 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 33 | 131 | 712 | 834 | 970 |
| TOTAL | $33 | $131 | $712 | $834 | $970 |
| Total Assets | $608,242 | $715,729 | $739,415 | $827,851 | $866,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,183 | 53,251 | 4,413 | 5,494 | 7,702 |
| TOTAL | $106,325 | $76,667 | $26,067 | $31,980 | $19,573 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 318 | 410 | 502 |
| TOTAL | $N/A | $N/A | $318 | $410 | $502 |
| Total Liabilities | $106,325 | $76,667 | $26,385 | $32,390 | $20,075 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,106 | 115,554 | 113,036 | 112,445 | 112,310 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,005,871 | -847,546 | -689,884 | -599,097 | -533,536 |
| Other shareholders' equity | -856 | 378 | 374 | -166 | -216 |
| TOTAL | $501,917 | $639,062 | $713,030 | $795,461 | $846,918 |
| Total Liabilities And Equity | $608,242 | $715,729 | $739,415 | $827,851 | $866,993 |